The antiplatelet activity of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, is mediated through inhibition of phospholipase C

Thrombosis Research

Volumn 92, Issue 2, 1998, Pages 53-64

  Sheu, Joen Rong ^a   Kan, Ya Chen ^a   Hung, Wei Chun ^a   Su, Ching Hua ^a   Lin, Chien Huang ^a   Lee, Yen Mei ^b   Yen, Mao Hsiung ^b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Arachidonic acid; Human platelet; Phosphoinositide breakdown; Rutaecarpine; Thromboxane A2

Indexed keywords

ALKALOID; CALCIUM ION; PHOSPHOLIPASE C INHIBITOR; RUTAECARPINE;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CHEMOLUMINESCENCE; CHINESE MEDICINE; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MICROSOME; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION INHIBITION;

ALKALOIDS; BLOOD PLATELETS; DRUGS, CHINESE HERBAL; ENZYME INHIBITORS; HUMANS; PHOSPHOLIPASE C; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS;

EID: 0032532671     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00112-1     Document Type: Article

References (34)

1. Li SC, Pen-Tsao Kang Mu. (republished by National Research Institute of Chinese Medicine, 1976, Taipei) 1596; Chapter 32, p. 1064.
2. Liao J.F., Chen C.F., Chow S.Y. Pharmacological studies of Chinese herbs. (9) Pharmacological effects of Evodiae Fructus. J Formosan Med Assoc. 79:1981;30-38.
3. Chow S.Y., Chen S.M., Yang C.M. Pharmacological studies on Chinese herbs (3). Analgesic effect of 27 Chinese drugs in mice. J Formosan Med Assoc. 75:1976;349-357.
4. Chen C.F., Chen S.M., Lin M.T., Chow S.Y. In vivo and in vitro studies on the mechanism of the cardiovascular effect of Wu-Chu-Yu (Evodiae fructus). Am J Chin Med. 1:1981;39-47.
5. Chang H.M., But P.P.H. Pharmacology and Applications of Chinese Materials Medica. Vol. I. 1987;World Scientific Publishing Co. Pte. Ltd, Singapore. p. 605.
6. Yang H.Y., Li S.Y., Chen C.F. Hypotensive effects of dehydroevodiamine, a quinazolinocarboline alkaloid isolated from Evodiae rutaecarp a. Asia Pacific J Pharmacol. 3:1988;191-195.
7. Yang M.C., Wu S.L., Kao J.S., Chen C.F. The hypotensive and negative chronotropic effect of dehydroevodiamine. Eur J Pharmacol. 182:1990;537-542.
8. Shoji N., Umeyama A., Takemoto T., Kajiwara A., Ohizumi Y. Isolation of evodiamine, a powerful cadiotonic principle, from Evodia rutaecarpa Bentham (Rutaceae). J Pharma Sci. 75:1986;612-613.
9. Yamahara J., Yamada T., Kitani T., Naiton Y., Fujimura H. Antianoxic action of evodiamine, and alkaloid in Evodia rutaecarpa fruit. J Ethnopharmacol. 27:1989;185-192.
10. Chiou W.F., Chou C.J., Shum A.Y.C., Chen C.F. The vasorelaxant effect of evodiamine in rat isolated mesenteric arteries. Mode of action Eur J Pharmacol. 215:1992;277-283.
11. Chiou W.F., Chou C.J., Liao J.F., Sham A.Y.C., Chen C.F. The mechanism of the vasodilator effect of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa. Eur J Pharmacol. 257:1994;59-66.
12. Sheu J.R., Hung W.C., Lee Y.M., Yen M.H. Mechanism of inhibition of platelet aggregation by rutaecarpine, an alkaloid isloated from Evodia rutaecarpa. Eur J Pharmacol. 318:1996;469-475.
13. Zhou Q., Hellermann G.R., Solomonson L.P. Nitric oxide release from resting human platelets. Thromb Res. 77:1995;87-96.
14. Huang T.F., Sheu J.R., Teng C.M. A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom. Biochem J. 277:1991;351-357.
15. + inducers with greatly improved fluorescence properties. J Biol Chem. 260:1985;3440-3445.
16. Kitagawa S., Shinohara T., Kametani F. Effects of alcohols on ADP-induced aggregation and membrane fluidity of gel-filtered bovine blood platelets. J Membrane Biol. 79:1984;97-102.
17. Sheu J.R., Teng C.M., Huang T.F. Triflavin, an RGD-containing antiplatelet peptide, binds to GPIIIa of ADP-stimulated platelets. Biochem Biophys Res Commun. 189:1992;1236-1242.
18. Sheu J.R., Lin C.H., Peng C.H., Huang T.F. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits the adhesion of tumor cells to matrix proteins via binding to multiple integrin receptors expressed on human hepatoma cells. Proc Soc Exp Biol Med. 213:1996;71-79.
19. Lowry D.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem. 193:1951;265-275.
20. 3H]arachidonic from human platelets stimulated by thrombin or collagen. Thromb Haemost. 72:1994;634-642.
21. 1-adrenoceptors in rat kidney mediates increased inositol phospholipid hydrolysis. Br J Pharmacol. 91:1987;367-376.
22. Radomski M.W., Palmer R.M.J., Moncada S. The anti-aggregating properties of vascular endothelium :interactions between prostacyclin a nd nitric oxide. Br J Pharmacol. 92:1987;639-646.
23. Salvemini D., DeNucci G., Gryglewski R.J., Van J.R. Human neutrophils and mononuclear cells inhibits platelet aggregation by releasing a nitric oxide-like factor. Proc Natl Acad Sci USA. 86:1989;6328-6332.
24. Mollace V., Salvemini D., Anggard E., Vane J. Nitric oxide from vascular smooth muscle cells:regulation of platelet reactivity and smooth muscle cell guanylate cyclase. Br J Pharmacol. 104:1991;633-639.
25. Metha J.L., Chen L.Y., Kone B.C., Mehta J.F., Turner P. Identification of constitute and inducible forms of nitric oxide synthase in human platelets. J Lab Clin Med. 125:1995;370-377.
26. Needleman P., Raz A., Ferrendelli J.A., Minkes M. Application of imidazole as a selective inhibitor thromboxane synthetase in human platelets. Proc Natl Acad Sci USA. 74:1977;1716-1720.
27. Nozawa Y., Nakasgima S., Nagata K. Phospholipid-mediated signalling in receptor activation of human platelets. Biochim Biophys Acta. 1082:1991;219-238.
28. Lloret S., Moreno J.J. In vitro and in vivo effects of the anti-inflammatory peptides, antiflammins. Biochem Pharmacol. 44:1992;37-41.
29. Broekman M.J., Ward J.W., Marcus A.J. Phospholipid metabolism in stimulated human platelets. Changes in phosphatidyl inositol, phosph atic acid and lysophospholipids. J Clin Invest. 66:1980;275-283.
30. Mene P., Dunn M.J. Prostaglandins and rat glomerular mesangial cell proliferation. Kidney Int. 37:1990;1256-1262.
31. Radomski M.W., Palmer R.M.J., Moncada S. Characterization of the L-arginine:nitric oxide pathway in human platelets. Br J Pharmacol. 101:1990;325-328.
32. Berridge M.J. Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol. Biochem J. 212:1983;849-858.
33. Bell R.L., Kennerly D.A., Stanford N., Majerus P.W. Diglyceride lipase. A pathway for arachidonic acid release from human platelets Proc Natl Acad Sci USA. 76:1979;3241-3258.
34. Mckean M.L., Smith J.B., Silver W.J. Formation of lysophosphatidylcholine in human platelets in response to thrombin. J Biol Chem. 256:1981;1522-1524.